AnnouncementAug 2026
Aug 2026 · Announcement under Regulation 30 (LODR)-Change in Management 1 Jul - Gopalakrishnan Kalianna appointed Sales Head effective August 1, 2026; Rohini Venkateswaran moves to Korea role.
Source: Bse
Procter & Gamble Hygiene and Health Care Limited (PGHH)
Small CapConsumer stocks · Small cap · NSE
Procter & Gamble Hygiene and Health Care Limited operates in Personal Care, within the Consumer sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
₹6,902
-246.50 · -3.45%
Market cap ₹21,969 Cr
Data qualityFresh enough for analysisQuote updated 21 Oct, 03:31 pm ISTDetails
Quote21 Oct, 03:31 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result29 Jul, 06:32 pm IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags03 May 2026
Coverage14/14 · 100%
Valuation2026-07-20 · Rf 6.8% · Consumer P/E 22.2 (n=441)
Technical timing lens
Trend score and candlestick chart
34BearishSMA20 -10.3% / mo · MACD + · near 52W low · sector -4.6pp vs Nifty 500 (3M)
Stock trend: 37
Sector RS: 31
Sector 3M: -10.2% vs Nifty 500 -5.6%
Consumer FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
PGHHD candles · FIT view-32.3%TODAY · PROVISIONALLatest price ₹6902.00 on 2026-10-21
Today's candle is provisional from the latest intraday quote; completed-candle scans remain unchanged.
Bar
-3.4%
RSI
37
MACD hist
60.00
52W pos
4%
2026-10-21O ₹7148.50H ₹7158.50L ₹6866.00C ₹6902.00Vol 11,245 shIntraday candle
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
PGHHNifty Consumer DurablesNifty 500
- PGHH
- -18.1%
- Nifty 500
- -5.6%
- Nifty Consumer Durables
- -9.7%
- Vs Nifty 500
- -12.5 pp
Chart stats
19 Oct 2026- From 52W high
- -50.2%
- 52W range position
- 7%
- ATR (14)
- 2.2%
- Volume vs 20D
- 0.58x
- Avg traded value
- ₹12.5 Cr
- 20D price channel
- ₹6,579 - ₹7,521
₹14,352
₹6,579 - ₹14,352
₹159.4
Latest completed session
20-session average
20.9% annualized volatility
Research snapshot
What the evidence says now
Investable fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is weak.
Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · UNDERVALUED65
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Bad0
Revenue -4.9% · PAT -34.4% YoY
Technical
Bearish34
Price trend and sector-relative-strength timing.
Valuation
Legacy model+14.9%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence79
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Bad · 0/100Rev -5% YoY · PAT -34% YoY · margin compression
Filed 29 Jul 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹891 Cr | -4.9% | -5.3% |
| EBITDA | ₹170 Cr | -36.1% | -22.0% |
| Operating margin | 19.0% | -900 bps | -400 bps |
| PAT | ₹126 Cr | -34.4% | -17.6% |
| PAT margin | 14.1% | -635 bps | -212 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- 27.80
- P/B
- 29.17
- EV/EBITDA
- 19.74
- Market Cap
- 21969.00Cr
Profitability
- ROE
- 115.00%
- ROCE
- 157.00%
- ROA
- 43.85%
- Dividend Y
- 3.40%
Growth (CAGR)
- Revenue 5Y
- 7.00%
- EPS 5Y
- 14.00%
- Revenue 3Y
- 3.00%
- EPS 3Y
- 14.00%
Balance Sheet
- Debt/Equity
- 0.00
- Interest Coverage
- 107.50×
- Altman Z
- 10.71
- Book Value
- 232.00
Cash Flow
- FCF Yield
- 4.26%
- FCF Positive Y
- 12/5
- OCF
- 924.00 Cr
- EPS TTM
- 243.59
Shareholding
- Promoter Hold
- 70.64%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 2%
Financial History
Updated 20/10/2026
Revenue
₹ CrLatest: 4,290+27.1% vs prev
Net Profit
₹ CrLatest: 856+34.4% vs prev
Return on Equity
%Latest: 114+31.5% vs prev
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Bearish setupTrend is weak — long-term trend down. RSI 37.
- Price < SMA20 < SMA50 < SMA200 — full bearish stack.
- SMA20 falling (~11.3% over last month) — short-term momentum negative.
- RSI(14) at 37 — sideways, no extreme reading.
- MACD above signal but histogram contracting — bullish momentum cooling.
- Within 5% of 52-week low — testing support.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
8
RS percentile
Stage 4 Downtrend
1M return
-4.5%
3M return
-18.1%
6M return
-31.5%
1Y return
-46.6%
RS 1D
0
RS 20D
+2
Sector rank
#9
Industry rank
#73
Stage evidence
- Price is 18.8% below the 30-week proxy.
- The 50-DMA is below the 30-week proxy and its slope is falling -5.6%.
- Both 3-month and 6-month returns are negative.
50-DMA
price below
200-DMA
price below
Sector
neutral
Industry
lagging
Relative-strength line vs Nifty 500 (base 100)
261 observations
19 Oct 2026Value 51.88+0.74%
RS vs Nifty 50052
Valuation & peers
U-Score 65 · legacy U-Score band UNDERVALUED · valuation evidence and comparable companies
Valuation & peers
U-Score 65 · legacy U-Score band UNDERVALUED · valuation evidence and comparable companies
Premium Compounder
Fundamental score breakdown
U band · UNDERVALUEDValuation4/30
Growth13/25
Quality20/20
Balance Sheet13/15
Cash Flow9/10
Piotroski
8/9 (+5)
Penalties
1
Raw sum
65
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
65/100 · legacy band UNDERVALUED
Positive drivers
- FCF yield is supportive at 4.3%.
- Piotroski is strong at 8/9.
- Fair-value margin of safety is positive at 14.9%.
Main drags
- Valuation is weaker at 4/30; verify the latest quarterly trend.
- Growth is weaker at 13/25; verify the latest quarterly trend.
- Balance sheet is weaker at 13/15; verify the latest quarterly trend.
Sector valuation model
Consumer valuation: PE/PEG and brand-quality premium
Consumer franchises can deserve higher multiples, but only when growth quality supports them.
Primary lens
PE and PEG relative to growth, ROE, margins, and brand strength.
Secondary checks
Volume growth, pricing power, distribution, same-store or category growth.
Main risk check
Premium valuation needs durable growth and margin resilience.
PE
27.8
PB
29.2
EV/EBITDA
19.7
ROE
115.0%
ROCE
157.0%
FCF Yield
4.3%
Debt/Equity
0.0
MoS
+14.9%
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
65
Previous: 65
Legacy U-Score band
UNDERVALUED
Previous: UNDERVALUED
Margin of safety
+14.9%
Previous: +11.9%
Score history
12 stored score snapshots. Latest stored move: +0 points.
21 Oct 2026
v4.3-runtime-valuation
65
65
65
65
65
65
65
65
65
65
65
65
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹1,127.63
-512.1% MoS
Growth-justified P/E
33.3
Growth-justified Value
₹8,111.55
+14.9% MoS
PEG
1.99
Comparable companies
Peers
Business-comparable peers in Consumer — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
ZYDUSWELL
Large
Zydus Wellness Limited
Consumer Goods
match 106
27
74.0
4.0%
-1280%
OVERVALUED
DEVYANI
Small
Devyani International Limited
Hospitality
match 84
29
—
-1.6%
—
OVERVALUED
VENTIVE
Small
Ventive Hospitality Limited
Hospitality
match 84
39
26.4
8.3%
+18%
WATCHLIST
CHALET
Large
Chalet Hotels Limited
Hospitality
match 82
54
34.8
19.0%
-5%
FAIR VALUE
EIHOTEL
Large
EIH Limited
Hospitality
match 81
50
26.0
14.5%
+20%
FAIR VALUE
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Procter & Gamble Hygiene and Health Care Limited operates in Personal Care, within the Consumer sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
79Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 88th percentile of the scored universe and 92nd percentile within Consumer. Main check: results consistency is weak at 34/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
20 docs text-extracted · 7 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
88th percentile
overall median 67 · Consumer: 92nd pctile, median 66 · Small: 90th pctile, median 66
Evidence depth
Financial-only
20 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
86
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
96
strong · leverage and solvency
Discipline
90
strong · capital discipline
Results
34
weak · quarterly consistency
Trust positives
- ▸Promoter holding is 70.6%.
- ▸Promoter pledge is zero.
- ▸FCF yield is positive at 3.5%.
- ▸12 years of positive FCF.
Trust risks
- ▸1/4 latest quarters had positive YoY PAT growth.
- ▸1 of the latest 4 quarters had PAT decline worse than 25% YoY.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Procter & Gamble Hygiene and Health Care Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
AnnouncementAug 2026
Aug 2026 · Announcement under Regulation 30 (LODR)-Change in Management 2d - Mohit Pradhan appointed VP, Feminine Hygiene from August 1, 2026; Girish Kalyanaraman exits June 30, 2026.
Source: Bse
Annual report
Reg. 34 (1) Annual Report. 17 Aug
Source: Bse
Annual report
Business Responsibility and Sustainability Reporting (BRSR) 17 Aug - Filed FY2025-26 Business Responsibility and Sustainability Report as part of the annual report.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 May - P&G Hygiene FY26 sales ₹4,290 crore, PAT ₹857 crore up 19%; final dividend ₹60 per share.
Source: Bse
Annual report
Annual Report 2026
Source: Bse
Annual report
Annual Report 2025
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.